GlassScriptPhysician profile
Marykathrine Ley
NPI 1306382726
$6,225.87
in general payments reported to CMS, 2019-2025
39 companies · $517 in 2025
The $517 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,584 · 2022: $1,319 · 2023: $1,974 · 2024: $831 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,307 · Education: $15.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,306.88 |
| Education | $15.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,148.39 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,126.27 | 2021-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $898.24 | 2021-2023 | Stiolto Respimat, Ofev, Spiriva Respimat |
| Viiv Healthcare Company | $375.95 | 2021-2024 | Dovato |
| Takeda Pharmaceuticals U.S.A., INC. | $284.94 | 2021-2025 | Glassia, Eohilia, Cuvitru |
| Amgen INC. | $251.59 | 2021-2025 | Tezspire |
| Baxter Healthcare | $189.69 | 2022-2023 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Inspire Medical Systems, INC. | $153.01 | 2023 | Inspire |
| United Therapeutics Corporation | $130.39 | 2021-2024 | Tyvaso, Orenitram |
| Genzyme Corporation | $125.21 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $121.86 | 2021-2025 | Dupixent |
| Mayne Pharma Commercial LLC | $112.37 | 2021-2022 | |
| Grifols USA, LLC | $111.92 | 2021-2022 | |
| Harmony Biosciences LLC | $111.71 | 2022-2023 | Wakix |
| Astellas Pharma US INC | $90.45 | 2022-2024 | Ambisome, Cresemba |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marykathrine Ley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.